{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:08:03Z","timestamp":1784092083144,"version":"3.55.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lymphoepithelioma-like intrahepatic cholangiocarcinoma (LEL-ICC) is a rare, Epstein-Barr virus (EBV)-associated subtype of intrahepatic cholangiocarcinoma (ICC). With fewer than 150 cases reported globally, its comprehensive clinicopathological spectrum and optimal management remain incompletely understood, necessitating updated, systematic evaluations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>This report describes a case of LEL-ICC incidentally discovered in a 71-year-old female patient. Imaging and gross pathological examinations revealed that the tumor had well-defined borders and a distinct pseudocapsule, a feature rarely emphasized in the description of such lesions. Histological examination showed that the tumor consisted of moderately to highly differentiated glandular structures, with a stroma composed of follicular lymphoid tissue. The tumor cells expressed cholangiocarcinoma markers (cytokeratin 7 and cytokeratin 19) but did not express markers of hepatocellular origin or those commonly associated with extrahepatic metastases. Combined immunohistochemical analysis revealed a wild-type expression pattern for p53, a Ki-67 proliferation index of approximately 10%, and positivity for EB virus-encoded small RNA (EBER); these findings collectively confirmed the final diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The lesion in this case presented with focal adenoid differentiation and an intact pseudocapsule, further enriching our understanding of the morphological characteristics of intrahepatic cholangiocarcinoma (ICC) with lymphoepithelial differentiation. This article also reviews the relevant literature and summarizes the etiology, diagnostic criteria, differential diagnosis, and treatment options for this disease. This study further confirms that EBER testing for hepatitis-associated tumors can effectively reduce misdiagnosis and holds significant clinical value.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1881159","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:43:05Z","timestamp":1784090585000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Clinicopathological features and literature review of a case of lymphoepithelioma-like intrahepatic cholangiocarcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Ruiping","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Pathology, Seventh People\u2019s Hospital of Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuling","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seventh People\u2019s Hospital of Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Seventh People\u2019s Hospital of Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhu","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seventh People\u2019s Hospital of Shanghai University of Traditional Chinese Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.11817\/j.issn.1672-7347.2024.230298","article-title":"Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma: a report of 3 cases and literature review","volume":"49","author":"Peng","year":"2024","journal-title":"J Cent South Univ (Med Sci)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1763411","article-title":"Comprehensive management of advanced lymphoepithelioma-like hepatocellular carcinoma with immune-related colitis: a case report and literature review","volume":"16","author":"Zhang","year":"2026","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2023.102244","article-title":"Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection","volume":"47","author":"Zheng","year":"2023","journal-title":"Clinics Res Hepatol Gastroenterol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231210174","article-title":"Potential missed opportunities for diagnosis of lymphoepithelioma-like intrahepatic cholangiocarcinoma: report of a rare case","volume":"51","author":"Tang","year":"2023","journal-title":"J Int Med Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1090580","article-title":"Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: two case reports and a literature review","volume":"13","author":"Sam Saji","year":"2023","journal-title":"Front Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/10668969241297260","article-title":"Epstein-Barr virus-positive lymphoepithelioma-like intrahepatic cholangiocarcinoma: a case report and literature review","volume":"33","author":"Ghandour","year":"2025","journal-title":"Int J Surg Pathol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1620328","article-title":"Case report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features","volume":"15","author":"Corallo","year":"2025","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13000-020-01035-6","article-title":"Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review","volume":"15","author":"Zhang","year":"2020","journal-title":"Diagn Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000001716","article-title":"Lymphoepithelioma-like intrahepatic cholangiocarcinoma is a distinct entity with frequent pTERT\/TP53 mutations and comprises 2 subgroups based on Epstein-Barr virus infection","volume":"45","author":"Tsai","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0046-8177(96)90460-8","article-title":"Clonal Epstein-Barr virus associated cholangiocarcinoma with lymphoepithelioma-like component","volume":"27","author":"Hsu","year":"1996","journal-title":"Hum Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.02.022","article-title":"Lymphoepithelioma-like carcinoma in liver","volume":"187","author":"Labgaa","year":"2017","journal-title":"Am J Pathol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/his.12455","article-title":"Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome","volume":"65","author":"Chan","year":"2014","journal-title":"Histopathology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.10.037","article-title":"Clinicopathologic features, tumor immune microenvironment and genomic landscape of EBV-associated intrahepatic cholangiocarcinoma","volume":"74","author":"Huang","year":"2021","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2214\/AJR.20.22937","article-title":"The CT and MRI features of primary intrahepatic lymphoepithelioma-like cholangiocarcinoma","volume":"216","author":"Yang","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-020-01303-4","article-title":"Lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection treated by radiofrequency ablation","volume":"14","author":"Nogami","year":"2021","journal-title":"Clin J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11949","article-title":"Programmed death-ligand 1 is upregulated in intrahepatic lymphoepithelioma-like cholangiocarcinoma","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-022-10346-3","article-title":"The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma","volume":"16","author":"Chiang","year":"2022","journal-title":"Hepatol Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i13.4089","article-title":"Lymphoepithelioma-like cholangiocarcinoma: a mimic of hepatocellular carcinoma on imaging features","volume":"21","author":"Liao","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2023.10079\/2023","article-title":"Lymphoepithelioma-like cholangiocarcinoma mimicking hepatocellular carcinoma","volume":"117","author":"Yu","year":"2025","journal-title":"Rev Esp Enferm Dig"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15339","article-title":"High PD-L1 level of advanced hepatic lymphoepithelioma-like carcinoma response favorably to lenvatinib plus toripalimab","volume":"113","author":"Zhu","year":"2022","journal-title":"Cancer Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.155848","article-title":"Clinicopathological analysis of lymphoepithelioma-like intrahepatic cholangiocarcinoma","volume":"268","author":"Li","year":"2025","journal-title":"Pathol Res Pract"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn-2025-139","article-title":"Primary Epstein-Barr virus-positive inflammatory follicular dendritic cell sarcoma concurrent with lymphoepithelioma-like intrahepatic cholangiocarcinoma and cavernous hemangioma in liver","volume":"14","author":"Jia","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/10668969241268392","article-title":"Lymphoepithelioma-like intrahepatic cholangiocarcinoma with massive multinucleated giant cell reaction","volume":"33","author":"Luyao","year":"2025","journal-title":"Int J Surg Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105769","article-title":"Clinical characteristics and prognosis of pulmonary lymphoepithelioma-like carcinoma: a multicenter cohort study of 1106 cases","volume":"10","author":"Hou","year":"2025","journal-title":"ESMO Open"},{"key":"B25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3350\/cmh.2021.0287","article-title":"Intrahepatic cholangiocarcinoma: tumour heterogeneity and its clinical relevance","volume":"28","author":"Komuta","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112151-20220517-00423","article-title":"Expert consensus on pathological diagnosis of intrahepatic cholangiocarcinoma (2022 edition)","volume":"51","year":"2022","journal-title":"Chin J Pathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41420-026-02999-y","article-title":"Harnessing the immune microenvironment: advances in nasopharyngeal carcinoma immunotherapy","volume":"12","author":"Zhu","year":"2026","journal-title":"Cell Death Discov"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020349","article-title":"Fibrin-associated large B-cell lymphoma shows frequent mutations related to immune surveillance and PTEN","volume":"142","author":"Boyer","year":"2023","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J Hepatol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1146933","article-title":"Case report: Primary lymphoepithelioma-like intrahepatic cholangiocarcinoma","volume":"13","author":"Liu","year":"2023","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1881159\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T04:43:30Z","timestamp":1784090610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1881159\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":30,"alternative-id":["10.3389\/fonc.2026.1881159"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1881159","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1881159"}}